To test whether the human 12-LOX inhibitor VLX-1005 (14) (Figure 1B) phenocopies deletion of the enzyme in our human gene replacement mice, we employed a similar STZ diabetes induction protocol. The gene discussed is ALOX12; the disease is diabetes mellitus.